Zhi Yang
- Cancer Research top 2%
- MicroRNA in disease regulation 8
- Cancer, Hypoxia, and Metabolism 6
- Oncology top 5%
- CAR-T cell therapy research 13
- Cancer Cells and Metastasis 11
- Hepatology top 5%
- Molecular Biology top 5%
- RNA modifications and cancer 5
- Geriatrics and Gerontology top 5%
-
- Virus-based gene therapy research 6
-
- Bone Tissue Engineering Materials 6
-
- Immunotherapy and Immune Responses 5
- Cited by
- Cancer ResearchOncologyHepatology
- Journals
- Journal of Clinical Oncology (2 papers)SHILAP Revista de lepidopterología (2 papers)Blood (1 paper)
- Partner nations
- ChinaUnited StatesJapan
In The Last Decade
Zhi Yang
103 papers receiving 3.0k citations
Peers
Comparison fields: 5 of 123
- Cancer Research 891
- Oncology 832
- Hepatology 209
- Molecular Biology 1.6k
- Geriatrics and Gerontology 76
Countries citing papers authored by Zhi Yang
This map shows the geographic impact of Zhi Yang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Zhi Yang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Zhi Yang more than expected).
Fields of papers citing papers by Zhi Yang
This network shows the impact of papers produced by Zhi Yang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Zhi Yang. The network helps show where Zhi Yang may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Zhi Yang, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2026 | 0 | |
| 2 | 2025 | 6 | |
| 3 | 2024 | 1 | |
| 4 | 2024 | 0 | |
| 5 | 2024 | 1 | |
| 6 | 2024 | 1 | |
| 7 | 2023 | 5 | |
| 8 | 2023 | 1 | |
| 9 | 2023 | 8 | |
| 10 | 2022 | 0 | |
| 11 | 2022 | 5 | |
| 12 | 2022 | 31 | |
| 13 | 2021 | 11 | |
| 14 | 2021 | 6 | |
| 15 | 2017 | 9 | |
| 16 | 2016 | 57 | |
| 17 | 2014 | 74 | |
| 18 | The effect of BDNF on maturation in-vitro and developmental competence of murine immature oocytes | 2009 | 1 |
| 19 | 2007 | 44 | |
| 20 | The Antitumor and Improving Immunological Functions Effect of Moxibustion | 2001 | 1 |
About Zhi Yang
Zhi Yang is a scholar working on Oncology, Cancer Research and Hepatology, having authored 113 papers that have together received 3.0k indexed citations. Recurring topics across this work include CAR-T cell therapy research (13 papers), Cancer Cells and Metastasis (11 papers), MicroRNA in disease regulation (8 papers), Virus-based gene therapy research (6 papers), Bone Tissue Engineering Materials (6 papers), Cancer, Hypoxia, and Metabolism (6 papers), RNA modifications and cancer (5 papers) and Immunotherapy and Immune Responses (5 papers). The work is most often cited by research in Cancer Research (891 citations), Oncology (832 citations) and Hepatology (209 citations). Zhi Yang has collaborated with scholars based in China, United States and Japan. Frequent co-authors include Cheng Qian, Juanjuan Shan, Yanmin Xu, Limei Liu, Junjie Shen, Xiu‐Wu Bian, You‐Hong Cui, Leina Ma, Chungang Liu and X Y Feng. Their work appears in journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and Blood.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.